These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28440547)

  • 1. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
    Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
    Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices.
    Iturrospe E; Da Silva KM; Talavera Andújar B; Cuykx M; Boeckmans J; Vanhaecke T; Covaci A; van Nuijs ALN
    J Chromatogr A; 2021 Jan; 1637():461807. PubMed ID: 33360078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue.
    Naz S; García A; Barbas C
    Anal Chem; 2013 Nov; 85(22):10941-8. PubMed ID: 24144172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
    Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.
    Zang X; Zhang J; Jiao P; Xue X; Lv Z
    J Proteome Res; 2022 Aug; 21(8):2011-2022. PubMed ID: 35856400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS.
    Neef SK; Hofmann U; Mürdter TE; Schwab M; Haag M
    Talanta; 2023 Aug; 260():124578. PubMed ID: 37119797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.
    Leuthold P; Schaeffeler E; Winter S; Büttner F; Hofmann U; Mürdter TE; Rausch S; Sonntag D; Wahrheit J; Fend F; Hennenlotter J; Bedke J; Schwab M; Haag M
    J Proteome Res; 2017 Feb; 16(2):933-944. PubMed ID: 27992229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Profiling of Tumor Tissues Unveils Metabolic Shifts in Non-Small Cell Lung Cancer Patients with Concurrent Diabetes Mellitus.
    Lyu X; Wang Y; Xu Y; Zhao Z; Liu H; Hu Z
    J Proteome Res; 2024 Sep; 23(9):3746-3753. PubMed ID: 39162688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.
    Klupczynska A; Dereziński P; Garrett TJ; Rubio VY; Dyszkiewicz W; Kasprzyk M; Kokot ZJ
    J Cancer Res Clin Oncol; 2017 Apr; 143(4):649-659. PubMed ID: 28168355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
    Liu Z; Yin P; Amathieu R; Savarin P; Xu G
    Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and identification of potential biomarkers of non-small cell lung cancer.
    Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
    Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
    Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and lipidome.
    Cao P; Wu S; Guo W; Zhang Q; Gong W; Li Q; Zhang R; Dong X; Xu S; Liu Y; Shi S; Huang Y; Zhang Y
    Metabolomics; 2021 Nov; 17(11):98. PubMed ID: 34729658
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.